Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

Recently approved vaccines have already shown remarkable protection in limiting SARS-CoV-2 associated disease. However, immunologic mechanism(s) of protection, as well as how boosting alters immunity to wildtype and newly emerging strains, remain incompletely understood. Here we deeply profiled the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Sq
Autors principals: Alter, Galit, Gorman, Matthew, Patel, Nita, Guebre-Xabier, Mimi, Zhu, Alex, Atyeo, Caroline, Pullen, Krista, Loos, Carolin, Goez-Gazi, Yenny, Carrion, Ricardo, Tian, Jing-Hui, Yuan, Dansu, Bowman, Kathryn, Zhou, Bin, Maciejewski, Sonia, McGrath, Marisa, Logue, James, Frieman, Matthew, Montefiori, David, Schendel, Sharon, Saphire, Erica Ollmann, Lauffenburger, Douglas, Greene, Ann, Portnoff, Alyse, Massare, Michael, Ellingsworth, Larry, Glenn, Gregory, Smith, Gale, Mann, Colin, Amanat, Fatima, Krammer, Florian
Format: Artigo
Idioma:Inglês
Publicat: American Journal Experts 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7899467/
https://ncbi.nlm.nih.gov/pubmed/33619473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-200342/v1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars